Bellicum Pharmaceuticals, Inc.
(NASDAQ : BLCM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.64%178.391.3%$493.87m
CELGCelgene Corporation
-0.78%90.201.3%$431.91m
GILDGilead Sciences, Inc.
-3.23%65.040.9%$395.98m
ILMNIllumina, Inc.
-1.79%293.203.5%$387.83m
BIIBBiogen Inc.
-0.41%231.271.3%$347.69m
ARRYArray BioPharma Inc.
0.00%46.498.1%$287.88m
REGNRegeneron Pharmaceuticals, Inc.
-1.64%298.112.6%$250.63m
ALXNAlexion Pharmaceuticals, Inc.
-2.00%120.802.0%$206.12m
VRTXVertex Pharmaceuticals Incorporated
-2.22%174.131.9%$160.59m
SRPTSarepta Therapeutics, Inc.
-1.56%149.2614.7%$158.59m
AAgilent Technologies, Inc.
-2.05%68.691.6%$152.75m
EXASExact Sciences Corporation
-1.73%114.8824.1%$131.59m
SGENSeattle Genetics, Inc.
-2.05%75.076.5%$108.91m
INCYIncyte Corporation
-0.95%80.542.5%$90.89m
BLUEBluebird Bio, Inc.
-2.22%138.1214.3%$88.46m

Company Profile

Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. It uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.